NanoBio In RSV Vaccine Research Effort With MerckNanobio Corp. Thursday announced a preclinical collaboration with a subsidiary of Merck & Co. Inc. focused on the development of a vaccine for Respiratory Syncytial Virus (RSV).

More From CBS Detroit

Best Places To Get A Hot Toddy
Best Sledding Hills
Real Time Traffic

Watch & Listen